nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Areflexia—Cisplatin—esophageal cancer	0.023	0.0575	CcSEcCtD
Ixabepilone—TUBB3—digestive system—esophageal cancer	0.00844	0.0511	CbGeAlD
Ixabepilone—Peripheral sensory neuropathy—Capecitabine—esophageal cancer	0.00803	0.0201	CcSEcCtD
Ixabepilone—Neurotoxicity—Cisplatin—esophageal cancer	0.00803	0.0201	CcSEcCtD
Ixabepilone—TUBB3—lung—esophageal cancer	0.00705	0.0427	CbGeAlD
Ixabepilone—Polyneuropathy—Capecitabine—esophageal cancer	0.00704	0.0176	CcSEcCtD
Ixabepilone—Trismus—Capecitabine—esophageal cancer	0.00687	0.0172	CcSEcCtD
Ixabepilone—Lower respiratory tract infection—Capecitabine—esophageal cancer	0.00671	0.0168	CcSEcCtD
Ixabepilone—Myelosuppression—Cisplatin—esophageal cancer	0.00664	0.0166	CcSEcCtD
Ixabepilone—TUBB2B—bronchus—esophageal cancer	0.00643	0.0389	CbGeAlD
Ixabepilone—TUBB—bronchus—esophageal cancer	0.00608	0.0368	CbGeAlD
Ixabepilone—TUBB6—epithelium—esophageal cancer	0.00606	0.0367	CbGeAlD
Ixabepilone—TUBB2A—bronchus—esophageal cancer	0.00605	0.0366	CbGeAlD
Ixabepilone—TUBB6—bronchus—esophageal cancer	0.00597	0.0361	CbGeAlD
Ixabepilone—TUBB—smooth muscle tissue—esophageal cancer	0.00595	0.036	CbGeAlD
Ixabepilone—TUBB2A—smooth muscle tissue—esophageal cancer	0.00592	0.0358	CbGeAlD
Ixabepilone—Arrhythmia supraventricular—Capecitabine—esophageal cancer	0.00592	0.0148	CcSEcCtD
Ixabepilone—Neurotoxicity—Capecitabine—esophageal cancer	0.00592	0.0148	CcSEcCtD
Ixabepilone—TUBB6—smooth muscle tissue—esophageal cancer	0.00584	0.0353	CbGeAlD
Ixabepilone—TUBB2B—trachea—esophageal cancer	0.00577	0.0349	CbGeAlD
Ixabepilone—TUBB—trachea—esophageal cancer	0.00546	0.033	CbGeAlD
Ixabepilone—TUBB2A—trachea—esophageal cancer	0.00543	0.0329	CbGeAlD
Ixabepilone—TUBB6—trachea—esophageal cancer	0.00536	0.0324	CbGeAlD
Ixabepilone—Dysaesthesia—Capecitabine—esophageal cancer	0.0053	0.0133	CcSEcCtD
Ixabepilone—TUBB4B—bronchus—esophageal cancer	0.00519	0.0314	CbGeAlD
Ixabepilone—Febrile neutropenia—Cisplatin—esophageal cancer	0.00517	0.0129	CcSEcCtD
Ixabepilone—TUBB4A—digestive system—esophageal cancer	0.00514	0.0311	CbGeAlD
Ixabepilone—TUBB4B—smooth muscle tissue—esophageal cancer	0.00507	0.0307	CbGeAlD
Ixabepilone—TUBB2B—digestive system—esophageal cancer	0.00497	0.03	CbGeAlD
Ixabepilone—TUBB2A—digestive system—esophageal cancer	0.00467	0.0283	CbGeAlD
Ixabepilone—TUBB4B—trachea—esophageal cancer	0.00466	0.0282	CbGeAlD
Ixabepilone—TUBB6—digestive system—esophageal cancer	0.00461	0.0279	CbGeAlD
Ixabepilone—Cardiomyopathy—Capecitabine—esophageal cancer	0.00448	0.0112	CcSEcCtD
Ixabepilone—Lymphopenia—Capecitabine—esophageal cancer	0.00448	0.0112	CcSEcCtD
Ixabepilone—Neurotoxicity—Methotrexate—esophageal cancer	0.0044	0.011	CcSEcCtD
Ixabepilone—TUBB4A—lung—esophageal cancer	0.00429	0.026	CbGeAlD
Ixabepilone—TUBB2B—lung—esophageal cancer	0.00415	0.0251	CbGeAlD
Ixabepilone—Mucosal inflammation—Capecitabine—esophageal cancer	0.00414	0.0104	CcSEcCtD
Ixabepilone—TUBB4B—digestive system—esophageal cancer	0.00401	0.0242	CbGeAlD
Ixabepilone—Cognitive disorder—Methotrexate—esophageal cancer	0.00395	0.00987	CcSEcCtD
Ixabepilone—TUBB—lung—esophageal cancer	0.00392	0.0237	CbGeAlD
Ixabepilone—TUBB2A—lung—esophageal cancer	0.0039	0.0236	CbGeAlD
Ixabepilone—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00386	0.00964	CcSEcCtD
Ixabepilone—TUBB6—lung—esophageal cancer	0.00385	0.0233	CbGeAlD
Ixabepilone—Febrile neutropenia—Capecitabine—esophageal cancer	0.00381	0.00953	CcSEcCtD
Ixabepilone—Infection—Carboplatin—esophageal cancer	0.00376	0.0094	CcSEcCtD
Ixabepilone—Bacterial infection—Methotrexate—esophageal cancer	0.0037	0.00924	CcSEcCtD
Ixabepilone—Embolism—Capecitabine—esophageal cancer	0.00357	0.00893	CcSEcCtD
Ixabepilone—Nail disorder—Capecitabine—esophageal cancer	0.00354	0.00884	CcSEcCtD
Ixabepilone—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.0034	0.00849	CcSEcCtD
Ixabepilone—Laryngeal pain—Capecitabine—esophageal cancer	0.00337	0.00841	CcSEcCtD
Ixabepilone—TUBB4B—lung—esophageal cancer	0.00335	0.0202	CbGeAlD
Ixabepilone—Neuralgia—Capecitabine—esophageal cancer	0.0033	0.00825	CcSEcCtD
Ixabepilone—Thrombosis—Capecitabine—esophageal cancer	0.00324	0.0081	CcSEcCtD
Ixabepilone—Ileus—Capecitabine—esophageal cancer	0.00324	0.0081	CcSEcCtD
Ixabepilone—Pain—Carboplatin—esophageal cancer	0.00324	0.00809	CcSEcCtD
Ixabepilone—Laryngitis—Capecitabine—esophageal cancer	0.00318	0.00795	CcSEcCtD
Ixabepilone—Mucosal inflammation—Methotrexate—esophageal cancer	0.00308	0.00771	CcSEcCtD
Ixabepilone—Body temperature increased—Carboplatin—esophageal cancer	0.00299	0.00748	CcSEcCtD
Ixabepilone—Skin exfoliation—Cisplatin—esophageal cancer	0.00297	0.00743	CcSEcCtD
Ixabepilone—Coagulopathy—Capecitabine—esophageal cancer	0.00295	0.00736	CcSEcCtD
Ixabepilone—TUBB4A—lymph node—esophageal cancer	0.00293	0.0178	CbGeAlD
Ixabepilone—Hyperaesthesia—Capecitabine—esophageal cancer	0.00292	0.0073	CcSEcCtD
Ixabepilone—Neuropathy—Cisplatin—esophageal cancer	0.00292	0.0073	CcSEcCtD
Ixabepilone—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.00287	0.00718	CcSEcCtD
Ixabepilone—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00285	0.00713	CcSEcCtD
Ixabepilone—Febrile neutropenia—Methotrexate—esophageal cancer	0.00284	0.00709	CcSEcCtD
Ixabepilone—TUBB2B—lymph node—esophageal cancer	0.00284	0.0172	CbGeAlD
Ixabepilone—Dysphonia—Capecitabine—esophageal cancer	0.00279	0.00697	CcSEcCtD
Ixabepilone—TUBB—lymph node—esophageal cancer	0.00268	0.0162	CbGeAlD
Ixabepilone—TUBB2A—lymph node—esophageal cancer	0.00267	0.0162	CbGeAlD
Ixabepilone—Embolism—Methotrexate—esophageal cancer	0.00266	0.00665	CcSEcCtD
Ixabepilone—TUBB6—lymph node—esophageal cancer	0.00263	0.0159	CbGeAlD
Ixabepilone—Nail disorder—Methotrexate—esophageal cancer	0.00263	0.00658	CcSEcCtD
Ixabepilone—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00254	0.00635	CcSEcCtD
Ixabepilone—Lacrimation increased—Capecitabine—esophageal cancer	0.00249	0.00622	CcSEcCtD
Ixabepilone—Burning sensation—Methotrexate—esophageal cancer	0.00246	0.00614	CcSEcCtD
Ixabepilone—Coordination abnormal—Capecitabine—esophageal cancer	0.00234	0.00584	CcSEcCtD
Ixabepilone—TUBB4B—lymph node—esophageal cancer	0.00229	0.0138	CbGeAlD
Ixabepilone—Hyponatraemia—Cisplatin—esophageal cancer	0.00227	0.00567	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00226	0.00565	CcSEcCtD
Ixabepilone—Colitis—Capecitabine—esophageal cancer	0.0022	0.0055	CcSEcCtD
Ixabepilone—Skin exfoliation—Capecitabine—esophageal cancer	0.00219	0.00547	CcSEcCtD
Ixabepilone—Neuropathy—Capecitabine—esophageal cancer	0.00215	0.00538	CcSEcCtD
Ixabepilone—Dehydration—Cisplatin—esophageal cancer	0.0021	0.00525	CcSEcCtD
Ixabepilone—Oesophagitis—Capecitabine—esophageal cancer	0.0021	0.00524	CcSEcCtD
Ixabepilone—Hypokalaemia—Cisplatin—esophageal cancer	0.00206	0.00514	CcSEcCtD
Ixabepilone—Sepsis—Capecitabine—esophageal cancer	0.00199	0.00498	CcSEcCtD
Ixabepilone—Bone disorder—Methotrexate—esophageal cancer	0.00189	0.00473	CcSEcCtD
Ixabepilone—Pancytopenia—Cisplatin—esophageal cancer	0.00185	0.00463	CcSEcCtD
Ixabepilone—Hot flush—Capecitabine—esophageal cancer	0.00178	0.00445	CcSEcCtD
Ixabepilone—Menopausal symptoms—Capecitabine—esophageal cancer	0.00176	0.00441	CcSEcCtD
Ixabepilone—Vasculitis—Methotrexate—esophageal cancer	0.00175	0.00437	CcSEcCtD
Ixabepilone—Respiratory failure—Methotrexate—esophageal cancer	0.00174	0.00435	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00172	0.00429	CcSEcCtD
Ixabepilone—Renal failure—Cisplatin—esophageal cancer	0.00171	0.00428	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00171	0.00427	CcSEcCtD
Ixabepilone—Myocardial infarction—Cisplatin—esophageal cancer	0.00171	0.00427	CcSEcCtD
Ixabepilone—Lethargy—Capecitabine—esophageal cancer	0.0017	0.00425	CcSEcCtD
Ixabepilone—Stomatitis—Cisplatin—esophageal cancer	0.0017	0.00424	CcSEcCtD
Ixabepilone—Hyponatraemia—Capecitabine—esophageal cancer	0.00167	0.00418	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00167	0.00416	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00165	0.00412	CcSEcCtD
Ixabepilone—CYP3A4—digestive system—esophageal cancer	0.00165	0.00996	CbGeAlD
Ixabepilone—Skin exfoliation—Methotrexate—esophageal cancer	0.00163	0.00407	CcSEcCtD
Ixabepilone—Dehydration—Capecitabine—esophageal cancer	0.00155	0.00387	CcSEcCtD
Ixabepilone—Urinary tract disorder—Cisplatin—esophageal cancer	0.00154	0.00386	CcSEcCtD
Ixabepilone—Connective tissue disorder—Cisplatin—esophageal cancer	0.00154	0.00384	CcSEcCtD
Ixabepilone—Urethral disorder—Cisplatin—esophageal cancer	0.00153	0.00383	CcSEcCtD
Ixabepilone—Hypokalaemia—Capecitabine—esophageal cancer	0.00152	0.00379	CcSEcCtD
Ixabepilone—Sepsis—Methotrexate—esophageal cancer	0.00148	0.0037	CcSEcCtD
Ixabepilone—Gastritis—Capecitabine—esophageal cancer	0.00147	0.00368	CcSEcCtD
Ixabepilone—Muscular weakness—Capecitabine—esophageal cancer	0.00147	0.00367	CcSEcCtD
Ixabepilone—Eye disorder—Cisplatin—esophageal cancer	0.00146	0.00365	CcSEcCtD
Ixabepilone—Cardiac disorder—Cisplatin—esophageal cancer	0.00145	0.00363	CcSEcCtD
Ixabepilone—Dysphagia—Capecitabine—esophageal cancer	0.00144	0.0036	CcSEcCtD
Ixabepilone—Immune system disorder—Cisplatin—esophageal cancer	0.00141	0.00353	CcSEcCtD
Ixabepilone—Mediastinal disorder—Cisplatin—esophageal cancer	0.00141	0.00352	CcSEcCtD
Ixabepilone—Angina pectoris—Capecitabine—esophageal cancer	0.0014	0.0035	CcSEcCtD
Ixabepilone—Alopecia—Cisplatin—esophageal cancer	0.00138	0.00345	CcSEcCtD
Ixabepilone—Pancytopenia—Capecitabine—esophageal cancer	0.00137	0.00342	CcSEcCtD
Ixabepilone—Malnutrition—Cisplatin—esophageal cancer	0.00136	0.0034	CcSEcCtD
Ixabepilone—Neutropenia—Capecitabine—esophageal cancer	0.00135	0.00336	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00134	0.00334	CcSEcCtD
Ixabepilone—Muscle spasms—Cisplatin—esophageal cancer	0.00131	0.00327	CcSEcCtD
Ixabepilone—Weight decreased—Capecitabine—esophageal cancer	0.0013	0.00325	CcSEcCtD
Ixabepilone—Pneumonia—Capecitabine—esophageal cancer	0.00129	0.00323	CcSEcCtD
Ixabepilone—Infestation—Capecitabine—esophageal cancer	0.00128	0.00321	CcSEcCtD
Ixabepilone—Infestation NOS—Capecitabine—esophageal cancer	0.00128	0.00321	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00126	0.00316	CcSEcCtD
Ixabepilone—Lethargy—Methotrexate—esophageal cancer	0.00126	0.00316	CcSEcCtD
Ixabepilone—Renal failure—Capecitabine—esophageal cancer	0.00126	0.00315	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00126	0.00314	CcSEcCtD
Ixabepilone—Myocardial infarction—Capecitabine—esophageal cancer	0.00126	0.00314	CcSEcCtD
Ixabepilone—Anaemia—Cisplatin—esophageal cancer	0.00126	0.00314	CcSEcCtD
Ixabepilone—Stomatitis—Capecitabine—esophageal cancer	0.00125	0.00313	CcSEcCtD
Ixabepilone—Jaundice—Capecitabine—esophageal cancer	0.00125	0.00313	CcSEcCtD
Ixabepilone—Urinary tract infection—Capecitabine—esophageal cancer	0.00125	0.00312	CcSEcCtD
Ixabepilone—Leukopenia—Cisplatin—esophageal cancer	0.00122	0.00304	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00121	0.00303	CcSEcCtD
Ixabepilone—Myalgia—Cisplatin—esophageal cancer	0.00116	0.00289	CcSEcCtD
Ixabepilone—Haemoglobin—Capecitabine—esophageal cancer	0.00116	0.00289	CcSEcCtD
Ixabepilone—Haemorrhage—Capecitabine—esophageal cancer	0.00115	0.00288	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00115	0.00287	CcSEcCtD
Ixabepilone—Hypoaesthesia—Capecitabine—esophageal cancer	0.00115	0.00286	CcSEcCtD
Ixabepilone—Urinary tract disorder—Capecitabine—esophageal cancer	0.00114	0.00284	CcSEcCtD
Ixabepilone—Connective tissue disorder—Capecitabine—esophageal cancer	0.00113	0.00283	CcSEcCtD
Ixabepilone—Urethral disorder—Capecitabine—esophageal cancer	0.00113	0.00282	CcSEcCtD
Ixabepilone—Oedema—Cisplatin—esophageal cancer	0.00111	0.00278	CcSEcCtD
Ixabepilone—Infection—Cisplatin—esophageal cancer	0.0011	0.00276	CcSEcCtD
Ixabepilone—Erythema multiforme—Capecitabine—esophageal cancer	0.00109	0.00272	CcSEcCtD
Ixabepilone—Nervous system disorder—Cisplatin—esophageal cancer	0.00109	0.00272	CcSEcCtD
Ixabepilone—Thrombocytopenia—Cisplatin—esophageal cancer	0.00109	0.00272	CcSEcCtD
Ixabepilone—Skin disorder—Cisplatin—esophageal cancer	0.00108	0.0027	CcSEcCtD
Ixabepilone—Eye disorder—Capecitabine—esophageal cancer	0.00108	0.00269	CcSEcCtD
Ixabepilone—Cardiac disorder—Capecitabine—esophageal cancer	0.00107	0.00267	CcSEcCtD
Ixabepilone—Anorexia—Cisplatin—esophageal cancer	0.00106	0.00265	CcSEcCtD
Ixabepilone—Angiopathy—Capecitabine—esophageal cancer	0.00105	0.00261	CcSEcCtD
Ixabepilone—Immune system disorder—Capecitabine—esophageal cancer	0.00104	0.0026	CcSEcCtD
Ixabepilone—Mediastinal disorder—Capecitabine—esophageal cancer	0.00104	0.00259	CcSEcCtD
Ixabepilone—Hypotension—Cisplatin—esophageal cancer	0.00104	0.00259	CcSEcCtD
Ixabepilone—Chills—Capecitabine—esophageal cancer	0.00103	0.00258	CcSEcCtD
Ixabepilone—Alopecia—Capecitabine—esophageal cancer	0.00102	0.00254	CcSEcCtD
Ixabepilone—Pancytopenia—Methotrexate—esophageal cancer	0.00102	0.00254	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00101	0.00253	CcSEcCtD
Ixabepilone—Mental disorder—Capecitabine—esophageal cancer	0.00101	0.00252	CcSEcCtD
Ixabepilone—Malnutrition—Capecitabine—esophageal cancer	0.001	0.00251	CcSEcCtD
Ixabepilone—Neutropenia—Methotrexate—esophageal cancer	0.001	0.0025	CcSEcCtD
Ixabepilone—Paraesthesia—Cisplatin—esophageal cancer	0.000997	0.00249	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000996	0.00249	CcSEcCtD
Ixabepilone—Dyspnoea—Cisplatin—esophageal cancer	0.00099	0.00247	CcSEcCtD
Ixabepilone—Decreased appetite—Cisplatin—esophageal cancer	0.000965	0.00241	CcSEcCtD
Ixabepilone—Muscle spasms—Capecitabine—esophageal cancer	0.000964	0.00241	CcSEcCtD
Ixabepilone—Pneumonia—Methotrexate—esophageal cancer	0.000961	0.0024	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000959	0.0024	CcSEcCtD
Ixabepilone—Infestation NOS—Methotrexate—esophageal cancer	0.000955	0.00239	CcSEcCtD
Ixabepilone—Infestation—Methotrexate—esophageal cancer	0.000955	0.00239	CcSEcCtD
Ixabepilone—Pain—Cisplatin—esophageal cancer	0.000949	0.00237	CcSEcCtD
Ixabepilone—Renal failure—Methotrexate—esophageal cancer	0.000939	0.00235	CcSEcCtD
Ixabepilone—Stomatitis—Methotrexate—esophageal cancer	0.000931	0.00233	CcSEcCtD
Ixabepilone—Anaemia—Capecitabine—esophageal cancer	0.000927	0.00232	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000903	0.00226	CcSEcCtD
Ixabepilone—Syncope—Capecitabine—esophageal cancer	0.000899	0.00225	CcSEcCtD
Ixabepilone—Leukopenia—Capecitabine—esophageal cancer	0.000898	0.00224	CcSEcCtD
Ixabepilone—Loss of consciousness—Capecitabine—esophageal cancer	0.000881	0.0022	CcSEcCtD
Ixabepilone—Body temperature increased—Cisplatin—esophageal cancer	0.000878	0.00219	CcSEcCtD
Ixabepilone—Cough—Capecitabine—esophageal cancer	0.000875	0.00219	CcSEcCtD
Ixabepilone—Haemoglobin—Methotrexate—esophageal cancer	0.000862	0.00215	CcSEcCtD
Ixabepilone—Haemorrhage—Methotrexate—esophageal cancer	0.000858	0.00214	CcSEcCtD
Ixabepilone—Chest pain—Capecitabine—esophageal cancer	0.000854	0.00213	CcSEcCtD
Ixabepilone—Myalgia—Capecitabine—esophageal cancer	0.000854	0.00213	CcSEcCtD
Ixabepilone—Arthralgia—Capecitabine—esophageal cancer	0.000854	0.00213	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000848	0.00212	CcSEcCtD
Ixabepilone—Urinary tract disorder—Methotrexate—esophageal cancer	0.000847	0.00212	CcSEcCtD
Ixabepilone—Urethral disorder—Methotrexate—esophageal cancer	0.000841	0.0021	CcSEcCtD
Ixabepilone—Oedema—Capecitabine—esophageal cancer	0.000818	0.00205	CcSEcCtD
Ixabepilone—Hypersensitivity—Cisplatin—esophageal cancer	0.000818	0.00204	CcSEcCtD
Ixabepilone—Infection—Capecitabine—esophageal cancer	0.000813	0.00203	CcSEcCtD
Ixabepilone—Erythema multiforme—Methotrexate—esophageal cancer	0.000811	0.00203	CcSEcCtD
Ixabepilone—Shock—Capecitabine—esophageal cancer	0.000805	0.00201	CcSEcCtD
Ixabepilone—Nervous system disorder—Capecitabine—esophageal cancer	0.000803	0.00201	CcSEcCtD
Ixabepilone—Eye disorder—Methotrexate—esophageal cancer	0.000801	0.002	CcSEcCtD
Ixabepilone—Thrombocytopenia—Capecitabine—esophageal cancer	0.000801	0.002	CcSEcCtD
Ixabepilone—Asthenia—Cisplatin—esophageal cancer	0.000797	0.00199	CcSEcCtD
Ixabepilone—Cardiac disorder—Methotrexate—esophageal cancer	0.000796	0.00199	CcSEcCtD
Ixabepilone—Skin disorder—Capecitabine—esophageal cancer	0.000795	0.00199	CcSEcCtD
Ixabepilone—Anorexia—Capecitabine—esophageal cancer	0.00078	0.00195	CcSEcCtD
Ixabepilone—Angiopathy—Methotrexate—esophageal cancer	0.000778	0.00194	CcSEcCtD
Ixabepilone—Immune system disorder—Methotrexate—esophageal cancer	0.000775	0.00194	CcSEcCtD
Ixabepilone—Mediastinal disorder—Methotrexate—esophageal cancer	0.000773	0.00193	CcSEcCtD
Ixabepilone—Chills—Methotrexate—esophageal cancer	0.000769	0.00192	CcSEcCtD
Ixabepilone—Hypotension—Capecitabine—esophageal cancer	0.000765	0.00191	CcSEcCtD
Ixabepilone—Diarrhoea—Cisplatin—esophageal cancer	0.00076	0.0019	CcSEcCtD
Ixabepilone—Alopecia—Methotrexate—esophageal cancer	0.000758	0.00189	CcSEcCtD
Ixabepilone—Mental disorder—Methotrexate—esophageal cancer	0.000751	0.00188	CcSEcCtD
Ixabepilone—Malnutrition—Methotrexate—esophageal cancer	0.000747	0.00187	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000746	0.00186	CcSEcCtD
Ixabepilone—Insomnia—Capecitabine—esophageal cancer	0.00074	0.00185	CcSEcCtD
Ixabepilone—Paraesthesia—Capecitabine—esophageal cancer	0.000735	0.00184	CcSEcCtD
Ixabepilone—Dyspnoea—Capecitabine—esophageal cancer	0.00073	0.00182	CcSEcCtD
Ixabepilone—Decreased appetite—Capecitabine—esophageal cancer	0.000711	0.00178	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000707	0.00177	CcSEcCtD
Ixabepilone—Vomiting—Cisplatin—esophageal cancer	0.000706	0.00176	CcSEcCtD
Ixabepilone—Fatigue—Capecitabine—esophageal cancer	0.000706	0.00176	CcSEcCtD
Ixabepilone—Rash—Cisplatin—esophageal cancer	0.0007	0.00175	CcSEcCtD
Ixabepilone—Pain—Capecitabine—esophageal cancer	0.0007	0.00175	CcSEcCtD
Ixabepilone—Constipation—Capecitabine—esophageal cancer	0.0007	0.00175	CcSEcCtD
Ixabepilone—Dermatitis—Cisplatin—esophageal cancer	0.000699	0.00175	CcSEcCtD
Ixabepilone—Anaemia—Methotrexate—esophageal cancer	0.00069	0.00172	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000669	0.00167	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—esophageal cancer	0.000668	0.00167	CcSEcCtD
Ixabepilone—Nausea—Cisplatin—esophageal cancer	0.000659	0.00165	CcSEcCtD
Ixabepilone—Cough—Methotrexate—esophageal cancer	0.000651	0.00163	CcSEcCtD
Ixabepilone—Abdominal pain—Capecitabine—esophageal cancer	0.000647	0.00162	CcSEcCtD
Ixabepilone—Body temperature increased—Capecitabine—esophageal cancer	0.000647	0.00162	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—esophageal cancer	0.000636	0.00159	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—esophageal cancer	0.000636	0.00159	CcSEcCtD
Ixabepilone—Chest pain—Methotrexate—esophageal cancer	0.000636	0.00159	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000631	0.00158	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000625	0.00144	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—XBP1—esophageal cancer	0.000621	0.00143	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000621	0.00143	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000621	0.00143	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—SLC30A7—esophageal cancer	0.000617	0.00142	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—SLC30A7—esophageal cancer	0.000617	0.00142	CbGpPWpGaD
Ixabepilone—TUBB4A—Orphan transporters—CREBBP—esophageal cancer	0.000613	0.00141	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000609	0.0014	CbGpPWpGaD
Ixabepilone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000608	0.0014	CbGpPWpGaD
Ixabepilone—Infection—Methotrexate—esophageal cancer	0.000605	0.00151	CcSEcCtD
Ixabepilone—Hypersensitivity—Capecitabine—esophageal cancer	0.000603	0.00151	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—XBP1—esophageal cancer	0.000602	0.00138	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.000598	0.00138	CbGpPWpGaD
Ixabepilone—Nervous system disorder—Methotrexate—esophageal cancer	0.000597	0.00149	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—esophageal cancer	0.000597	0.00149	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—SLC30A7—esophageal cancer	0.000595	0.00137	CbGpPWpGaD
Ixabepilone—Skin disorder—Methotrexate—esophageal cancer	0.000592	0.00148	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—XBP1—esophageal cancer	0.000588	0.00135	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000588	0.00135	CbGpPWpGaD
Ixabepilone—Asthenia—Capecitabine—esophageal cancer	0.000587	0.00147	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000581	0.00134	CbGpPWpGaD
Ixabepilone—Anorexia—Methotrexate—esophageal cancer	0.000581	0.00145	CcSEcCtD
Ixabepilone—Pruritus—Capecitabine—esophageal cancer	0.000579	0.00145	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—SLC30A7—esophageal cancer	0.000577	0.00133	CbGpPWpGaD
Ixabepilone—Hypotension—Methotrexate—esophageal cancer	0.000569	0.00142	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—SLC30A7—esophageal cancer	0.000564	0.0013	CbGpPWpGaD
Ixabepilone—TUBB4B—Orphan transporters—CREBBP—esophageal cancer	0.000561	0.00129	CbGpPWpGaD
Ixabepilone—Diarrhoea—Capecitabine—esophageal cancer	0.00056	0.0014	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000557	0.00128	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000557	0.00128	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000557	0.00128	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000555	0.00128	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000555	0.00128	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000555	0.00139	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—esophageal cancer	0.000551	0.00138	CcSEcCtD
Ixabepilone—Paraesthesia—Methotrexate—esophageal cancer	0.000547	0.00137	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—esophageal cancer	0.000543	0.00136	CcSEcCtD
Ixabepilone—Dizziness—Capecitabine—esophageal cancer	0.000541	0.00135	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000536	0.00123	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—HIST1H2BM—esophageal cancer	0.000535	0.00123	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000532	0.00122	CbGpPWpGaD
Ixabepilone—Decreased appetite—Methotrexate—esophageal cancer	0.00053	0.00132	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.000528	0.00122	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—XBP1—esophageal cancer	0.000528	0.00122	CbGpPWpGaD
Ixabepilone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000526	0.00131	CcSEcCtD
Ixabepilone—Fatigue—Methotrexate—esophageal cancer	0.000525	0.00131	CcSEcCtD
Ixabepilone—Pain—Methotrexate—esophageal cancer	0.000521	0.0013	CcSEcCtD
Ixabepilone—Vomiting—Capecitabine—esophageal cancer	0.00052	0.0013	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000519	0.00119	CbGpPWpGaD
Ixabepilone—Rash—Capecitabine—esophageal cancer	0.000516	0.00129	CcSEcCtD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000516	0.00119	CbGpPWpGaD
Ixabepilone—Dermatitis—Capecitabine—esophageal cancer	0.000516	0.00129	CcSEcCtD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000514	0.00118	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000514	0.00118	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000513	0.00118	CbGpPWpGaD
Ixabepilone—Headache—Capecitabine—esophageal cancer	0.000513	0.00128	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00051	0.00117	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00051	0.00117	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000509	0.00117	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000508	0.00117	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—SLC30A7—esophageal cancer	0.000506	0.00116	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000498	0.00125	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000497	0.00114	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.000496	0.00114	CbGpPWpGaD
Ixabepilone—Nausea—Capecitabine—esophageal cancer	0.000486	0.00122	CcSEcCtD
Ixabepilone—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000484	0.00111	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—XBP1—esophageal cancer	0.000483	0.00111	CbGpPWpGaD
Ixabepilone—Abdominal pain—Methotrexate—esophageal cancer	0.000482	0.0012	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—esophageal cancer	0.000482	0.0012	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000481	0.00111	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MAD2L1—esophageal cancer	0.000472	0.00109	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—EP300—esophageal cancer	0.000472	0.00109	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00047	0.00108	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000467	0.00107	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000467	0.00107	CbGpPWpGaD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—EP300—esophageal cancer	0.000465	0.00107	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.000464	0.00107	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.000464	0.00107	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—SLC30A7—esophageal cancer	0.000463	0.00107	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000456	0.00105	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.000453	0.00104	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000451	0.00104	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00045	0.00104	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Methotrexate—esophageal cancer	0.000449	0.00112	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—HIST1H2BM—esophageal cancer	0.000443	0.00102	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.000438	0.00101	CbGpPWpGaD
Ixabepilone—Asthenia—Methotrexate—esophageal cancer	0.000437	0.00109	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000436	0.001	CbGpPWpGaD
Ixabepilone—Pruritus—Methotrexate—esophageal cancer	0.000431	0.00108	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000427	0.000982	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.000422	0.000972	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000422	0.000971	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000418	0.000962	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000417	0.000959	CbGpPWpGaD
Ixabepilone—Diarrhoea—Methotrexate—esophageal cancer	0.000417	0.00104	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—PSME2—esophageal cancer	0.000415	0.000955	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—PSME1—esophageal cancer	0.000415	0.000955	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—HIST1H2BM—esophageal cancer	0.000405	0.000932	CbGpPWpGaD
Ixabepilone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000403	0.000928	CbGpPWpGaD
Ixabepilone—Dizziness—Methotrexate—esophageal cancer	0.000403	0.00101	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.0004	0.000921	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MAD2L1—esophageal cancer	0.000391	0.000901	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—EP300—esophageal cancer	0.000391	0.000899	CbGpPWpGaD
Ixabepilone—Vomiting—Methotrexate—esophageal cancer	0.000387	0.000968	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000386	0.000889	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—EP300—esophageal cancer	0.000385	0.000887	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.000384	0.000885	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.000384	0.000885	CbGpPWpGaD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000384	0.000884	CbGpPWpGaD
Ixabepilone—Rash—Methotrexate—esophageal cancer	0.000384	0.00096	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—esophageal cancer	0.000384	0.000959	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000383	0.000882	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—ACTB—esophageal cancer	0.000382	0.00088	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—ACTB—esophageal cancer	0.000382	0.00088	CbGpPWpGaD
Ixabepilone—Headache—Methotrexate—esophageal cancer	0.000382	0.000954	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—BUB1B—esophageal cancer	0.000378	0.000869	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—ACTB—esophageal cancer	0.000369	0.00085	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000368	0.000846	CbGpPWpGaD
Ixabepilone—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000367	0.000843	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000363	0.000835	CbGpPWpGaD
Ixabepilone—Nausea—Methotrexate—esophageal cancer	0.000362	0.000905	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CHEK2—esophageal cancer	0.000359	0.000826	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MAD2L1—esophageal cancer	0.000358	0.000824	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—ACTB—esophageal cancer	0.000358	0.000823	CbGpPWpGaD
Ixabepilone—TUBB4B—G2/M Transition—EP300—esophageal cancer	0.000358	0.000823	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—EP300—esophageal cancer	0.000353	0.000811	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.000352	0.000809	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.000352	0.000809	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00035	0.000806	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.00035	0.000805	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—ACTB—esophageal cancer	0.00035	0.000805	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—HSPA5—esophageal cancer	0.000346	0.000795	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—HSPA5—esophageal cancer	0.000346	0.000795	CbGpPWpGaD
Ixabepilone—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000345	0.000793	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—PSME2—esophageal cancer	0.000344	0.000791	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—PSME1—esophageal cancer	0.000344	0.000791	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CALR—esophageal cancer	0.000335	0.00077	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CALR—esophageal cancer	0.000335	0.00077	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—HSPA5—esophageal cancer	0.000334	0.000768	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—GHRL—esophageal cancer	0.000329	0.000757	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—GHRL—esophageal cancer	0.000329	0.000757	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—FBXW7—esophageal cancer	0.000324	0.000745	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—FBXW7—esophageal cancer	0.000324	0.000745	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CALR—esophageal cancer	0.000323	0.000744	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—HSPA5—esophageal cancer	0.000323	0.000744	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.00032	0.000736	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—GHRL—esophageal cancer	0.000318	0.000732	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000317	0.000729	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—HSPA5—esophageal cancer	0.000316	0.000727	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—PSME2—esophageal cancer	0.000314	0.000723	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—PSME1—esophageal cancer	0.000314	0.000723	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—ACTB—esophageal cancer	0.000314	0.000723	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CALR—esophageal cancer	0.000313	0.000721	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—BUB1B—esophageal cancer	0.000313	0.00072	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—FBXW7—esophageal cancer	0.000313	0.00072	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—GHRL—esophageal cancer	0.000308	0.000708	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CALR—esophageal cancer	0.000306	0.000705	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—FBXW7—esophageal cancer	0.000303	0.000697	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—GHRL—esophageal cancer	0.000301	0.000693	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000298	0.000686	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CHEK2—esophageal cancer	0.000298	0.000685	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000296	0.000682	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—FBXW7—esophageal cancer	0.000296	0.000682	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000292	0.000673	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—ACTB—esophageal cancer	0.000287	0.000661	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—BUB1B—esophageal cancer	0.000286	0.000658	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000284	0.000654	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000284	0.000654	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—HSPA5—esophageal cancer	0.000284	0.000653	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000283	0.00065	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000279	0.000641	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CALR—esophageal cancer	0.000275	0.000633	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000275	0.000633	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000275	0.000632	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000273	0.000628	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000273	0.000628	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000273	0.000627	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CHEK2—esophageal cancer	0.000272	0.000626	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—GHRL—esophageal cancer	0.00027	0.000622	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—FBXW7—esophageal cancer	0.000266	0.000612	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000266	0.000612	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000264	0.000606	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00026	0.000598	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—HSPA5—esophageal cancer	0.00026	0.000597	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000255	0.000587	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CALR—esophageal cancer	0.000252	0.000579	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00025	0.000574	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—GHRL—esophageal cancer	0.000247	0.000569	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—FBXW7—esophageal cancer	0.000243	0.00056	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00024	0.000553	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000239	0.00055	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000233	0.000537	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000226	0.00052	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000224	0.000516	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000222	0.000511	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RB1—esophageal cancer	0.00022	0.000505	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000219	0.000504	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000214	0.000491	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000207	0.000475	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000205	0.000472	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000204	0.000469	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—RB1—esophageal cancer	0.000196	0.000452	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000193	0.000444	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000182	0.00042	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000182	0.00042	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000182	0.000419	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000176	0.000405	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN2A—esophageal cancer	0.000173	0.000397	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000171	0.000392	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000168	0.000387	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000167	0.000384	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000166	0.000383	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000163	0.000375	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—RB1—esophageal cancer	0.000163	0.000374	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00016	0.000368	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.00016	0.000368	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000158	0.000364	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000158	0.000363	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.00015	0.000345	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—EP300—esophageal cancer	0.00015	0.000345	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00015	0.000345	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—RB1—esophageal cancer	0.000149	0.000342	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000146	0.000336	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—esophageal cancer	0.000146	0.000335	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2A—esophageal cancer	0.000143	0.000329	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1A—esophageal cancer	0.000141	0.000324	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000137	0.000315	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000135	0.000311	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—EP300—esophageal cancer	0.000134	0.000309	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000131	0.000301	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2A—esophageal cancer	0.000131	0.000301	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000131	0.000301	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000128	0.000294	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000126	0.00029	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000124	0.000286	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000124	0.000284	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—esophageal cancer	0.000121	0.000278	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.00012	0.000276	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.00012	0.000275	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000118	0.000272	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MYC—esophageal cancer	0.000117	0.000269	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1A—esophageal cancer	0.000117	0.000269	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000114	0.000262	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—EP300—esophageal cancer	0.000111	0.000256	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—esophageal cancer	0.00011	0.000254	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000108	0.000249	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1A—esophageal cancer	0.000107	0.000246	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—EP300—esophageal cancer	0.000102	0.000234	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—esophageal cancer	9.91e-05	0.000228	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MYC—esophageal cancer	9.69e-05	0.000223	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—esophageal cancer	9.6e-05	0.000221	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MYC—esophageal cancer	8.86e-05	0.000204	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—esophageal cancer	7.96e-05	0.000183	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—esophageal cancer	7.28e-05	0.000167	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	6.45e-05	0.000148	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—BLVRB—esophageal cancer	6.45e-05	0.000148	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	5.48e-05	0.000126	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CA1—esophageal cancer	5.48e-05	0.000126	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CA2—esophageal cancer	5.01e-05	0.000115	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PLCE1—esophageal cancer	4.66e-05	0.000107	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ADH7—esophageal cancer	4.66e-05	0.000107	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.09e-05	9.4e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TYMP—esophageal cancer	3.91e-05	8.99e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.8e-05	8.74e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALOX15—esophageal cancer	3.7e-05	8.52e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TPI1—esophageal cancer	3.53e-05	8.13e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.53e-05	8.13e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.39e-05	7.79e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.26e-05	7.5e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.23e-05	7.43e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GNG7—esophageal cancer	3.07e-05	7.07e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.88e-05	6.63e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.74e-05	6.3e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.71e-05	6.23e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.57e-05	5.9e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ENO1—esophageal cancer	2.57e-05	5.9e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PSME2—esophageal cancer	2.53e-05	5.82e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PSME1—esophageal cancer	2.53e-05	5.82e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.18e-05	5.02e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.05e-05	4.72e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.87e-05	4.31e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.8e-05	4.13e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.2e-05	2.76e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NOS3—esophageal cancer	1.08e-05	2.47e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—esophageal cancer	9.84e-06	2.26e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—EP300—esophageal cancer	8.18e-06	1.88e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6.05e-06	1.39e-05	CbGpPWpGaD
